Circadian rhythm of melatonin in patients with hypertension;Rytm dobowy melatoniny u chorych z nadciśnieniem samoistnym

Polski Merkuriusz Lekarski

Volumn 16, Issue 97, 2004, Pages 50-54

  Ostrowska, Zofia ^a   Kos Kudła, Beata ^b   Marek, Bogdan ^b   Kajdaniuk, Dariusz ^b   Wołkowska, Kinga ^a   Świȩtochowska, Elzbieta ^a   Górski, Janusz ^a   Szapska, Bozena ^a  

^a Zaklad Biochemii Klinicznej w Zabrzu   (Poland)

^b Kat Patofizjol/Endokrynol Zabrzu   (Poland)

Author keywords

Daily rhythm; Hypertension; Melatonin

Indexed keywords

MELATONIN;

ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HYPERTENSION; MALE; SALIVA LEVEL; ADULT; BLOOD PRESSURE MONITORING; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RADIOIMMUNOASSAY; SALIVA;

ADULT; BLOOD PRESSURE MONITORING, AMBULATORY; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; FEMALE; HUMANS; HYPERTENSION; MALE; MELATONIN; MIDDLE AGED; RADIOIMMUNOASSAY; SALIVA;

EID: 4344713042     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J. Hypertens., 1999, 17, 151-183.
2. Andrew R. i wsp.: Analysis of biogenic amines in plasma of hypertensive patients and a control group. Neurochem. Res., 1993, 18, 1179-82.
3. Arangino S. i wsp.: Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. Am. J. Cardiol., 1999, 83, 1417-19.
4. Benot S. i wsp.: Physiological levels of melatonin contribute to the total antioxidative capacity of human serum. J. Pineal Res., 1999, 27, 59-64.
5. Birau N. i wsp.: Hypotensive effect of melatonin in essential hypertension. IRCS Med. Sci., 1981, 9, 906-909.
6. Cagnacci A. i wsp.: Influence of melatonin administration on the circulation of women. Am. J. Physiol., 1998, 274, R335-338.
7. Chuang J.I., Chen S.S., Lin M.T.: Melatonin decreases brain serotonin release, arterial pressure and heart rate in rats. Pharmacology, 1993, 47, 91-97.
8. Cohen M. i wsp.: Melatonin/noretisterone contraception. W: Melatonin and the pineal gland - from basic science to clinical application. Touitou Y. i wsp. (red.) Elsevier, Amsterdam 1993, 339-345.
9. Finocchiaro L.M. i wsp.: Pineal hyperactivity in spontaneously hypertensive rats: muscarinic regulation of indole metabolism. Clin. Sci. (Lond.), 1990, 79, 437-442.
10. Girouard H. i wsp.: Vasorelaxant effects of the chronic treatment with melatonin on mesenteric artery and aorta of spontaneously hypertensive rats. J. Hypertens., 2001, 19, 1369-77.
11. Halberg F., Tong Y., Johnson E.A.: Circadian system phase as aspect of temporal morphology: procedure and illustrative examples. W: The cellular aspects of biorythms. von Mayerbach H. (red.) Springer Verlag, Berlin 1967, 1-12.
12. Holmes S.W., Sugden D.: The effect of melatonin on pinealectomy-induced hypertension in the rat. Br. J. Pharmacol., 1976, 56, 360-361.
13. Karasek M.: Szyszynka i melatonina. PWN, Warszawa - Łodź 1997, 106.
14. Karppanen H., Airaksinen M.M., Sarkimaki I.: Effect in rats of pinealectomy and oxypertine on spontaneous locomotor activity and blood pressure during various light schedules. Ann. Med. Exp. Biol. Fenn., 1973, 51, 93-103.
15. Kawashima K. i wsp.: Antihypertensive action of melatonin in the spontaneously hypertensive rat. Clin. Exp. Theo. Pract., 1987, A9, 1121-31.
16. Kilic E. i wsp.: Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia. J. Cereb. Blood. Flow Metab., 1999, 19, 511-516.
17. Kim C.Y., Lee B.N., Kim J.S.: Effects of maternal-melatonin treatment on open-field behaviors and hypertensive phenotype in spontaneously hypertensive rats' (SHR) offspring. Exp. Anim., 2002, 51, 69-74.
18. Laflamme K.A. i wsp.: Impaired basal sympathetic tone and alpha 1-adrenergic responses in associations with the hypotensive effect of melatonin in spontaneously hypertensive rats. Am. J. Hypertens., 1998, 11, 219-229.
19. Marchioli R.: Antioxidant vitamins and prevention of cardiovascular disease: laboratory, epidemiological and clinical trial data. Pharmacol. Res., 1999, 40, 227-238.
20. Rapoport S.I. i wsp.: Melatonin production in hypertensive patients. Klin. Med. (Mosk.), 2000, 78, 21-24.
21. Satake N. i wsp.: Vasorelaxing action of melatonin in rat isolated aorta: possible endothelium dependent relaxation. Gen. Pharmacol., 1991, 22, 1127-1133.
22. Sewerynek E.: Melatonin and the cardiovascular system. Neuroendocrinol. Lett., 2002, 23, 79-83.
23. Visvanathan M., Laitinen J.T., Saavedra J.M.: Differential expression of melatonin receptors in spontaneously hypertensive rats. Neuroendocrinology, 1992, 56, 864-870.
24. Weekley L.B.: Melatonin-induced relaxation of rat aorta: Interaction with adrenergic agonists. J. Pineal Res., 1991, 11, 28-34.
25. Weinstock M., Blotnik S., Segal M.: Seasonal variation in the development of stress-induced systolic hypertension in the rat. J. Hypertens., 1985, 3, Suppl. 3, 107-109.
26. Wetterberg L. i wsp.: Circadian rhythm of melatonin release from pineal hypothalamus and pituitary in hypertensive rats. Prog. Clin. Biol, Res., 1990, 341B, 145-153.
27. Wu L., Wang R., de Champlain J.: Enhanced inhibition by melatonin of α-adrenoreceptor-induced aortic contraction and inositol phosphate in vascular smooth muscle cells from spontaneously hypertensive rats. J. Hypertens., 1998, 16, 339-347.
28. Zaslavskaia R.M. i wsp.: Capozide-50 alone and in combination with melatonin in therapy of hypertension. Klin. Med. (Mosk.), 2002, 78, 39-41.
29. Zaslavskaia R.M. i wsp.: Comparative study of the effectiveness of Cozaar monotherapy and Cozaar and melatonin combined therapy in aged patients with hypertension. Klin. Med. (Mosk.), 1998, 76, 49-51.
30. Zaslavskaia R.M. i wsp.: Time-dependent effects of antihypertensive agents and chronocorrecting action of melatonin in patients with arterial hypertension. Vestn. Ross. Akad. Med. Nauk, 2000, 36-41.